Logo image of USWS

US WELL SERVICES INC (USWS) Stock Fundamental Analysis

NASDAQ:USWS - Nasdaq - US91274U3095 - Common Stock - Currency: USD

7.41  +0.19 (+2.63%)

After market: 7.24 -0.17 (-2.29%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to USWS. USWS was compared to 62 industry peers in the Energy Equipment & Services industry. USWS has a bad profitability rating. Also its financial health evaluation is rather negative. USWS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year USWS has reported negative net income.
In the past year USWS had a positive cash flow from operations.
USWS Yearly Net Income VS EBIT VS OCF VS FCFUSWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA -22.57%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USWS Yearly ROA, ROE, ROICUSWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 200 400 600

1.3 Margins

Industry RankSector Rank
OM -25.29%
PM (TTM) -32.83%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USWS Yearly Profit, Operating, Gross MarginsUSWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 -40 -60 -80

More info and screens

1

2. Health

2.1 Basic Checks

USWS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for USWS has been reduced compared to 1 year ago.
Compared to 1 year ago, USWS has a worse debt to assets ratio.
USWS Yearly Shares OutstandingUSWS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M
USWS Yearly Total Debt VS Total AssetsUSWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.2 Solvency

USWS has an Altman-Z score of -1.85. This is a bad value and indicates that USWS is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of -3.11 indicates that USWS is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -3.11
Debt/FCF N/A
Altman-Z -1.85
ROIC/WACCN/A
WACC4.37%
USWS Yearly LT Debt VS Equity VS FCFUSWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M 300M

2.3 Liquidity

USWS has a Current Ratio of 0.72. This is a bad value and indicates that USWS is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.63 indicates that USWS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.63
USWS Yearly Current Assets VS Current LiabilitesUSWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M

More info and screens

4

3. Growth

3.1 Past

USWS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.36%, which is quite impressive.
USWS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.94%.
USWS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -27.19% yearly.
EPS 1Y (TTM)64.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.97%
Revenue 1Y (TTM)-16.94%
Revenue growth 3Y-27.19%
Revenue growth 5YN/A
Sales Q2Q%-12.73%

3.2 Future

USWS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.77% yearly.
The Revenue is expected to grow by 20.38% on average over the next years. This is a very strong growth
EPS Next Y74.03%
EPS Next 2Y40.38%
EPS Next 3Y25%
EPS Next 5Y17.77%
Revenue Next Year-8.55%
Revenue Next 2Y18.93%
Revenue Next 3Y19.5%
Revenue Next 5Y20.38%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USWS Yearly Revenue VS EstimatesUSWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
USWS Yearly EPS VS EstimatesUSWS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

USWS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year USWS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USWS Price Earnings VS Forward Price EarningsUSWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -14.36
USWS Per share dataUSWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

USWS's earnings are expected to grow with 25.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.38%
EPS Next 3Y25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for USWS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

US WELL SERVICES INC

NASDAQ:USWS (10/31/2022, 8:00:01 PM)

After market: 7.24 -0.17 (-2.29%)

7.41

+0.19 (+2.63%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-10 2022-08-10/amc
Earnings (Next)11-22 2022-11-22/bmo
Inst Owners0.04%
Inst Owner Change0%
Ins Owners102.51%
Ins Owner Change0%
Market Cap95.05M
Analysts45.71
Price Target7.04 (-4.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-38.58%
Min EPS beat(2)-55.34%
Max EPS beat(2)-21.81%
EPS beat(4)1
Avg EPS beat(4)-25.56%
Min EPS beat(4)-55.34%
Max EPS beat(4)14.26%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)10.96%
Min Revenue beat(2)2.39%
Max Revenue beat(2)19.53%
Revenue beat(4)3
Avg Revenue beat(4)2.47%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)19.53%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF 7.51
P/B N/A
P/tB N/A
EV/EBITDA -14.36
EPS(TTM)-9.28
EYN/A
EPS(NY)-0.48
Fwd EYN/A
FCF(TTM)-5.35
FCFYN/A
OCF(TTM)0.99
OCFY13.31%
SpS16.01
BVpS-7.01
TBVpS-10.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -25.29%
PM (TTM) -32.83%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity -3.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 311.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.63
Altman-Z -1.85
F-Score4
WACC4.37%
ROIC/WACCN/A
Cap/Depr(3y)122.71%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.97%
EPS Next Y74.03%
EPS Next 2Y40.38%
EPS Next 3Y25%
EPS Next 5Y17.77%
Revenue 1Y (TTM)-16.94%
Revenue growth 3Y-27.19%
Revenue growth 5YN/A
Sales Q2Q%-12.73%
Revenue Next Year-8.55%
Revenue Next 2Y18.93%
Revenue Next 3Y19.5%
Revenue Next 5Y20.38%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-202.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.63%
OCF growth 3YN/A
OCF growth 5YN/A